Mr. Yufang Shi, Director of the Institute for Translational Medicine of the University of Soochow and President of the non-profit institute Wuxi Sinotide New Drug Discovery, signed two agreements yesterday – May 20th – in Rome with Tor Vergata Oncoscience, the research center of Tor Vergata University of Rome.
With such an important signature, the institutions aim at encouraging the mobility of PhD students between the two Universities and to share expertise, research and laboratory activities.
A strong international relationship
This is the first step of a collaboration agreement that is part of other prestigious international scientific activities carried out in recent years, with ever greater impetus by our institution, consolidating the relationship with the University of Soochow.
Some Chinese students had in fact been admitted to the Doctoral Programme in “Biochemistry and Molecular Biology” of the Experimental Medicine Department at Tor Vergata University, under the cooperation agreement between the two Universities.
Mobility for students and research
This first phase of the three-year renewable agreement includes study and research mobility programmes for students and a scientific cooperation to be held in the laboratories of Tor Vergata University of Rome or at the Institute for Translational Medicine, University of Soochow, China.
The agreement was signed by Rector Giuseppe Novelli, with professors Gerry Melino, Mauro Piacentini and Eleonora Candi.
🇨🇳 Soochow University
Soochow University colloquially known in Chinese as Suda (苏大, Sūdà) is a university in Suzhou, Jiangsu, China. The school is part of the Chinese Ministry of Education’s Project 211, and a Jiangsu provincial key comprehensive university. The School of Humanities, School of Textile and Clothing Engineering, School of Chemistry, Chemical Engineering and Materials Science, and School of Medicine are the university’s most visibly distinguished schools.